# US 2019/0316120 A1 · Automated cell processing methods, modules, instruments, and systems

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0316120 A1
- Document ID: US20190316120A1
- Status: Published application
- Kind: A1
- Application number: 16/423,289
- Filed: 2019-05-28
- Published: 2019-10-17
- Earliest claimed: 2017-06-30
- Assignees: Inscripta, Inc.
- Applicants: Inscripta, Inc.
- Inventors: Don Masquelier; Phillip Belgrader; Jorge Bernate; Ryan Gill; Kevin Ness
- Web page: https://patentgrep.com/patent/US20190316120A1

## CPC

- C12N 15/1082: {Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors}
- C12M 23/44: {Multiple separable units; Modules}
- C12M 33/14: {with filters, sieves or membranes}
- C12M 35/00: {Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion (machines for extracting juice from animal or plant tissue by electroplasmolysis A23N1/006, processes employing electric or wave energy B01J19/08; treatment of microorganisms or enzymes with electrical or wave energy C12N13/00; methods for cell fusion C12N15/02; introduction of foreign genetic material C12N15/87)}
- C12M 37/04: {Seals}
- C12M 41/36: {of biomass, e.g. colony counters or by turbidity measurements (electrooptical investigation of individual particles G01N15/14, flow cytometers G01N15/1404)}
- C12M 41/48: {Automatic or computerized control (automatic analysis G01N35/00)}
- C12M 43/00: {Combinations of bioreactors or fermenters with other apparatus}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 15/102: {Mutagenizing nucleic acids}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12Q 1/6865: Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
- C40B 40/02: Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2800/80: Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

In an illustrative embodiment, automated multi-module cell editing instruments are provided to automate multiple edits into nucleic acid sequences inside one or more cells.

## Claims

### Claim 1

A method of creating a cell library of at least 5,000 edited cells using an automated stand-alone multi-module cell editing instrument for nuclease-directed genome editing, comprising the steps of:
providing live cells in a receptacle configured to receive cells;
providing a library of rationally-designed nucleic acids comprising sequences to facilitate nuclease-directed genome edits in the cells in a receptacle configured to receive nucleic acids;
growing the live cells in a growth module;
transforming the live cells in a transformation module with the library of rationally-designed nucleic acids;
providing conditions in a nuclease-directed editing module to allow nuclease-directed editing of nucleic acids in the cells; and
using an automated liquid handling system to move liquids from the receptacle configured to receive the cells to the growth module, from the growth module to the transformation module, from the receptacle configured to receive the rationally-designed nucleic acids to the transformation module, and from the transformation module to the nuclease-directed editing module without user intervention, wherein the nuclease-directed genome edits created in the automated stand-alone multi-module cell editing instrument result in a cell library comprising at least 5,000 cells with rationally-designed genome edits.

### Claim 2 (depends on 1)

The method of claim 1, wherein the rationally-designed genome edits in the cells creates a saturation mutagenesis cell library.

### Claim 3 (depends on 1)

The method of claim 1, wherein the rationally-designed genome edits in the cells creates a promoter swap cell library.

### Claim 4 (depends on 1)

The method of claim 1, wherein the rationally-designed genome edits in the cells creates a terminator swap cell library.

### Claim 5 (depends on 1)

The method of claim 1, wherein the rationally-designed genome edits in the cells creates a SNP swap cell library.

### Claim 6 (depends on 1)

The method of claim 1, wherein the rationally-designed genome edits in the cells creates a promoter and terminator swap cell library.

### Claim 7 (depends on 1)

The method of claim 1, wherein the library comprises at least 100,000 edited cells.

### Claim 8 (depends on 7)

The method of claim 7, wherein the library comprises at least 1,000,000 edited cells.

### Claim 9 (depends on 1)

The method of claim 1, wherein the nuclease-directed genome editing is CRISPR-directed genome editing.

### Claim 10 (depends on 1)

The method of claim 1, wherein the nuclease-directed genome editing is TALEN-directed genome editing.

### Claim 11 (depends on 1)

The method of claim 1, wherein the automated liquid handling system moves the cell library comprising individual cells with rationally-designed genome edits from the nuclease-directed editing module to the growth module.

### Claim 12

A method of creating a cell library of at least 5,000 cells using an automated stand-alone multi-module cell editing instrument for nuclease-directed genome editing, comprising the steps of:
providing a cell receptacle configured to receive cells;
providing a nucleic acid receptacle configured to receive rationally-designed nucleic acids comprising sequences to facilitate nuclease-directed genome editing events in the cells;
filtering the cells in a filtration module configured to render the cells electrocompetent;
transforming the electrocompetent cells in a transformation module configured to introduce the rationally-designed nucleic acids into the cells;
providing conditions in a nuclease-directed editing module to allow nuclease-directed editing of nucleic acids in the cells; and
using an automated liquid handling system to move liquids from the receptacle configured to receive cells to the filtration module, from the filtration module to the transformation module, from the receptacle configured to receive rationally-designed nucleic acids to the transformation module, and from the transformation module to the nuclease-directed editing module without user intervention, wherein the nuclease-directed genome edits created in the automated stand-alone multi-module cell editing instrument result in a cell library comprising at least 5,000 cells with rationally-designed genome edits.

### Claim 13 (depends on 12)

The method of claim 12, wherein the rationally-designed genome edits in the cells creates a saturation mutagenesis cell library.

### Claim 14 (depends on 12)

The method of claim 12, wherein the rationally-designed genome edits in the cells creates a promoter swap cell library.

### Claim 15 (depends on 12)

The method of claim 12, wherein the rationally-designed genome edits in the cells creates a terminator swap cell library.

### Claim 16 (depends on 12)

The method of claim 12, wherein the rationally-designed genome edits in the cells creates a SNP swap cell library.

### Claim 17 (depends on 12)

The method of claim 12, wherein the rationally-designed genome edits in the cells creates a promoter and terminator swap cell library.

### Claim 18 (depends on 12)

The method of claim 12, wherein the library comprises at least 100,000 edited cells.

### Claim 19 (depends on 18)

The method of claim 18, wherein the library comprises at least 1,000,000 edited cells.

### Claim 20 (depends on 12)

The method of claim 12, wherein the nuclease-directed genome editing is CRISPR-directed genome editing.
